Year: 2011
Type: review
Abstract: Please cite this paper as: Air. (2012) Influenza neuraminidase. Influenza and Other Respiratory Viruses 6(4), 245–256. Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as a vaccine target despite evidence that inclusion of neuraminidase in the subunit vaccine gives increased protection. This article describes current knowledge on the structure, enzyme activity, and antigenic significance of neuraminidase.
Author: Gillian M. Air
Institution: University of Oklahoma Health Sciences Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G228338467, G2633095754, G4489152561, Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised, New Influenza A Neuraminidase Inhibitors for Biodefense, Human & mouse antibodies against influenza virus, Human &mouse antibodies against influenza virus, Protein Carbohydrate Interactions in Cell Communication
OpenAlex ID: W2322798543
